A Phase 1, Open-Label, Fixed-Sequence 2-Period Study To Investigate The Effect Of Multiple Doses Of Itraconazole On The Single Dose Pharmacokinetics of Palbociclib (PD-0332991) In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 08 Jul 2014
At a glance
- Drugs Palbociclib (Primary) ; Itraconazole
- Indications Breast cancer; Colorectal cancer; Glioblastoma; Liposarcoma; Mantle-cell lymphoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Pfizer
- 27 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 08 May 2014 New trial record